SecBot SecBot
8-K ·Filed Aug 28, 2026

PDEX

PRO DEX INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed2mo ago SEC0001079973-26-001196
Actionable Insight • Neutral

The CEO bonus tied to 'sales growth and fiscal 2026 financial performance exceeding plan' is a soft positive signal on recent operating trends, but no specific financial figures were disclosed. Monitor the next 10-Q for actual revenue and earnings data to validate the performance claim.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
PDEX ▲ +12.75% at T+20d
NEUTRAL call +12.75% · α vs SPY +12.94% · entry $62.10 → $70.02
Next anchor: T+60d in 27d
Latest observation: T+39 +12.37% FF3 residual α
Entry = T+0 close
Aug 28, 2026
via day close
T+1d
-1.13%
call -1.13% · α -0.44%
$61.40
settled 8w ago
T+5d
+6.94%
call +6.94% · α +7.08%
$66.41
settled 8w ago
T+20d
+12.75%
call +12.75% · α +12.94%
$70.02
settled 29d ago
T+60d
Pending
in 27d

Price Chart

Loading chart...

Executive Summary

Pro-Dex disclosed discretionary cash bonuses for its CEO ($140,000) and CFO ($60,000) approved on August 26, 2026. The CEO's bonus was explicitly tied to sales growth and fiscal 2026 financial performance exceeding plan, providing a positive signal about recent operational results. This is a routine compensatory arrangement with no officer departures or red flags, making the filing neutral with low market impact.

Key Facts

  • Compensation Committee approved a $140,000 discretionary cash bonus for CEO Richard L. Van Kirk on August 26, 2026.
  • CFO Alisha K. Charlton received a $60,000 discretionary cash bonus.
  • CEO bonus was based on sales growth and fiscal 2026 financial performance exceeding plan.
  • Both bonuses will be paid in cash on September 3, 2026.
  • No officer departures, resignations, or appointments were disclosed.

Financial Impact

Total cash bonus of $200,000 ($140,000 CEO + $60,000 CFO) to be paid in September 2026.

cash

Risk Factors

  • No financial statements or specific performance metrics were provided to substantiate the 'exceeding plan' claim.
  • Discretionary bonuses are routine and do not guarantee sustained operational improvement.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (PDEX) — Batch item 10001079973-26-001196
Document: 0001079973-26-001196-index.html0001079973-26-001196
Document: 0001079973-26-001196.txt0001079973-26-001196
8-K Filing (PDEX) — Batch item 40001079973-26-001196
Document: 0001079973-26-001196-index.html0001079973-26-001196
Document: 0001079973-26-001196.txt0001079973-26-001196
7 reports for PDEX
Performance horizon
Filters
Rows
Reports for PDEX — sortable, filterable
TypeNow
Oct 6, 2026
21d ago
DEFA14A
NEUTRAL ★ 5/10
$62.80awaiting T+20—$62.27 (−0.84%)
Oct 6, 2026
21d ago
DEF 14A
NEUTRAL ★ 4/10
$62.80awaiting T+20—$62.27 (−0.84%)
Sep 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$66.91 $62.27▼ −6.93%▼ −9.66%$62.27 (−6.93%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$62.81 $62.49▼ −0.50%▼ −2.37%$62.27 (−0.85%)
Aug 28, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$62.10 $70.02▲ +12.75%▲ +12.94%$62.27 (+0.27%)
Jun 17, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$64.37 $59.08▼ −8.22%▼ −8.75%$62.27 (−3.26%)
Apr 30, 2026
25w ago
8-K
MIXED ★ 5/10
$48.36 $66.93▲ +38.40%▲ +33.12%$62.27 (+28.76%)
Showing 7 of 7

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 28, 2026